跳至主要内容
临床试验/NCT04281667
NCT04281667进行中(未招募)4 期

Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery - a Prospective, Randomized Controlled Trial

Helsinki University Central Hospital3 个研究点 分布在 1 个国家目标入组 604 人开始时间: 2020年3月18日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
进行中(未招募)
入组人数
604
试验地点
3
主要终点
Comprehensive Complication Index

研究概览

简要总结

MOBILE2 is a randomized controlled trial comparing mechanical and oral antibiotic bowel preparation to mechanical bowel preparation only in patients undergoing anterior rectal resection with primary anastomosis. Primary endpoint is Comprehensive Complication Index within 30 days from surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for anterior rectal resection with primary anastomosis

排除标准

  • Emergency operation
  • Bowel obstruction
  • Existing stoma
  • Other reason preventing mechanical bowel preparation
  • Allergy to neomycin or metronidazole
  • Age < 18 years
  • Lack of co-operation
  • Exclusion criteria after randomization:
  • Patient did not undergo surgery
  • Anterior resection was not performed
  • Colonic anastomosis was not performed

研究组 & 干预措施

Mechanical Bowel Preparation and Oral Antibiotics

Experimental

Mechanical Bowel Preparation and Oral Antibiotics

干预措施: Oral Antibiotics (Drug)

Mechanical Bowel Preparation and Oral Antibiotics

Experimental

Mechanical Bowel Preparation and Oral Antibiotics

干预措施: Mechanical Bowel Preparation (Drug)

Mechanical Bowel Preparation Only

Active Comparator

Mechanical Bowel Preparation Only

干预措施: Placebo (Drug)

Mechanical Bowel Preparation Only

Active Comparator

Mechanical Bowel Preparation Only

干预措施: Mechanical Bowel Preparation (Drug)

结局指标

主要结局

Comprehensive Complication Index

时间窗: Within 30 days from surgery

Comprehensive Complication Index score

次要结局

  • Surgical Site Infection(Within 30 days from surgery)
  • Lenght of hospital stay(Within hospital stay, estimated on average 7 days)
  • Mortality(Within 90 days from surgery)
  • Adjuvant therapy(Within 6 months from surgery)
  • Anastomotic dehiscence(Within 30 days from surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ville Sallinen

Adj. Prof.

Helsinki University Central Hospital

研究点 (3)

Loading locations...

相似试验